Usefulness of Clinical Evaluation, Troponins, and C-Reactive Protein in Predicting Mortality Among Stable Hemodialysis Patients

American Journal of Cardiology

Volumn 98, Issue 9, 2006, Pages 1283-1287

  Kanwar, Manpreet ^a   Hashem, Mustafa ^b   Rosman, Howard ^a   Kamalakannan, Desikan ^a   Cheema, Aamir ^c   Ali, Arshad ^d   Gardin, Julius ^a   Maciejko, James J ^a  

^a ST JOHN HOSPITAL AND MEDICAL CENTER   (United States)

^b Henry Ford Wyandotte Hospital   (United States)

^c JOHNS HOPKINS HOSPITAL   (United States)

^d UPMC Susquehanna   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; TROPONIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HEMODIALYSIS; HUMAN; ISCHEMIC HEART DISEASE; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; TREATMENT OUTCOME;

ADULT; AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CORONARY DISEASE; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MICHIGAN; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RENAL DIALYSIS; RISK FACTORS; ROC CURVE; TREATMENT OUTCOME; TROPONIN I; TROPONIN T;

EID: 33750990495     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2006.05.064     Document Type: Article

References (20)

1. National Institute of Health, and National Institutes of Diabetes and Digestive and Kidney Diseases. United States Renal Data System, USRDS 2002 annual data report: atlas of end-stage renal disease in the United States (2002), National Institute of Health, National Institutes of Diabetes and Digestive and Kidney Diseases, Bethesda, MD 467-488
2. Muller-Bardorff M., Hallermayer K., Schröder A., Ebert C., Borgya A., Gerhardt W., Remppis A., Zehelein J., and Katus H.A. Improved troponin T ELISA specific for cardiac troponin T isoform: assay development and analytical validation. Clin Chem 43 (1997) 458-466
3. Venge P., Lindahl B., and Wallentin L. New generation cardiac troponin I assay for the Access immunoassay system. Clin Chem 47 (2001) 959-961
4. Pearson T.A., Mensah G.A., Alexander R.W., Anderson J.L., Cannon R.A., Criqui M., Fadl Y.Y., Fortmann S.P., Hong Y., Myers G.L., et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107 (2003) 499-511
5. Apple F.S., Murakami M.M., Pearce L.A., and Herzog C.A. Predictive value of cardiac troponins I and T for subsequent death in end stage renal disease. Circulation 106 (2002) 2941-2945
6. Fehr T., Knoflach A., Ammann P., Pei P., and Binswanger U. Differential use of cardiac troponin T versus I in hemodialysis patients. Clin Nephrol 59 (2003) 35-39
7. Dierkes J., Domröse U., Westphal S., Ambrosch A., Bosselmann H., Neumann K.H., and Luley C. Cardiac troponin T predicts mortality in patients with end-stage renal disease. Circulation 102 (2000) 1964-1969
8. Roppolo L.P., Fitzgerald R., Dillow J., Ziegler T., Rice M., and Maisel A. A comparison of troponin T and troponin I as predictors of cardiac events in patients undergoing chronic dialysis at a veteran's hospital: a pilot study. J Am Coll Cardiol 34 (1999) 448-454
9. Ooi D.S., Zimmerman D., Graham J., and Wells G.A. Cardiac troponin T predicts long-term outcomes in hemodialysis patients. Clin Chem 4 (2001) 412-417
10. Khan N.A., Hemmelgarn B.R., Tonelli M., Thompson C.R., and Levin A. Prognostic value of troponin T and I among asymptomatic patients with end stage renal disease: a meta-analysis. Circulation 112 (2005) 3088-3096
11. deFillipi C., Wasserman S., Rosanio S., Tiblier E., Sperger H., Tocchi M., Christenson R., Uretsky B., Smiley M., Gold J., et al. Cardiac troponin T and C-reactive protein for predicting prognosis, coronary atherosclerosis, and cardiomyopathy in patients undergoing long-term hemodialysis. JAMA 290 (2003) 353-359
12. Iliou M.C., Fumeron C., Benoit M.O., Tuppin P., Calonge V.M., Moatti N., Buisson C., and Jacquot C. Prognostic value of cardiac markers in end stage renal disease: Chronic Hemodialysis and New Cardiac Markers Evaluation (CHANCE) study. Am J Kidney Dis 42 (2003) 513-523
13. Freda B.J., Tang W.H.W., Lente F.V., Peacock W.F., and Francis G.S. Cardiac troponins in renal insufficiency-review and clinical implications. J Am Coll Cardiol 40 (2002) 2065-2071
14. Khan I.A., Wattanasuwan N., Mehta N.J., Tun A., Singh N., Singh H.K., Vasavada B.C., and Sacchi T.J. Prognostic value of serum cardiac troponin I in ambulatory patients with chronic renal failure undergoing long-term hemodialysis. J Am Coll Cardiol 38 (2001) 991-998
15. Zimmerman J., Herrlinger S., Pruy A., Metzger T., and Wanner C. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 55 (1999) 648-658
16. Yeun J., Levine R.A., Mantadilok V., and Kaysen G.A. C-reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients. Am J Kidney Dis 35 (2000) 469-476
17. Boulier A., Jaussent I., Terrier N., Maurice F., Rivory J.P., Chalabi L., Boularan A.M., Delcourt C., Dupuy A.M., Canaud B., and Cristol J.P. Measurement of circulating troponin Ic enhances the prognostic value of C-reactive protein in hemodialysis patients. Nephrol Dial Transplant 19 (2004) 2313-2318
18. Owen W., and Lowrie E.G. C-Reactive protein as an outcome predictor for maintenance hemodialysis patients. Kidney Int 54 (1998) 627-663
19. NCEP Expert Panel. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285 (2001) 2486-2497
20. Kanwar M., Hashem M., Rosman H., Kamalakannan D., Cheema A., Ali A., Gardin J., and Maciejko J.J. Medication use among dialysis patients in the DMMS. United States Renal Data System. Dialysis Morbidity and Mortality Study. Am J Kid Dis 32 suppl (1998) S60-S68